MEDEZE Group Public Company Limited (SET: MEDEZE) has announced robust financial performance for the first quarter of 2025, ended 31 March 2025. The stem cell and immune cell services provider reported a substantial increase in both top-line revenue and net profit compared to the same period last year.
For 1Q25, MEDEZE posted total revenue of Baht 228.74 million, an impressive increase of 20% from Baht 190.00 million recorded in 1Q24. Revenue from sales and services, the Group’s core operation, grew by 12% year-on-year to Baht 205.08 million.
Profitability also saw significant gains. Net profit for the quarter reached Baht 74.63 million, marking a 27% increase compared to Baht 58.91 million reported in 1Q24. The net profit margin improved year-on-year by 5% to 33%. Operating profit (EBITDA) demonstrated strong growth as well, increasing by 26% year-on-year to Baht 101.82 million, with the EBITDA margin rising 12% to 50%. The gross profit margin was maintained at 78%, consistent with the previous year.
Key business developments during the quarter included the establishment of MEDEZE Hair Renaissance, a new subsidiary focused on hair follicle cell services, which contributed revenue in its first quarter of operation. The Group also signed an MOU to expand its cell storage base through dealers and explored opportunities in the Philippines market.
Looking ahead, MEDEZE has set a 2025 revenue target exceeding Baht 1,000 million, projecting continued strong growth.
